Latest From Adherium Ltd.
This week's roundup includes CEO appointments by Gyroscope Therapeutics, Urovant Sciences and Nevoii Pharmaceuticals, in addition to various other high-level appointments by companies including, Horizon Pharma, Veloxis Pharmaceuticals, Modus Therapeutics and Adherium.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
This week's roundup includes board appointments by Pharmalink, Oxular, Decibel Therapeutics and executive appointments by various companies including e-Therapeutics, where Amgen's current executive director of corporate development has been appointed CEO, Cleave Biosciences and IXICO.
SmartInhaler developer Adherium has appointed the co-founder of MicroDose Therapeutx to head up its European base in Amsterdam, Netherlands.
- Monitoring Equipment & Devices
- Drug Delivery
- Therapeutic Areas
- Respiratory, Pulmonary
- Nexus6 Ltd.
- New Zealand
- Parent & Subsidiaries
- Adherium Ltd.
- Senior Management
Arik Anderson, Group CEO
Timothy A Marcotte, CFO
Nigel Devine, VP, Production & Dev.
Maggie Scott, Head, Clin. Ops.
Vik Panda, VP, Mktg.
- Contact Info
Phone: 9 307 2771
8 Commerce St.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.